REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

15/06/2018 15:25

RNS Number : 6054R
Hikma Pharmaceuticals Plc
15 June 2018
 


Notification and public disclosure of transactions by persons discharging managerial responsibilities
Surendera Tyagi



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Surendera Tyagi




2


Reason for the notification




a)


Position/status


Chief Scientific Officer and Global Head of R&D




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Market purchase of 1,400 Ordinary Shares by IG Markets Limited for and on behalf of Surendera Tyagi.




c)


Price(s) and volume(s)


Price(s): £14.00
Volume(s): 1,400




d)


Aggregated information


Volume: 1,400
Price: £19,600.00




e)


Date of the transaction


14 June 2018




f)


Place of the transaction


London Stock Exchange (XLON)



 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSGDLDDBBGIU